Olympus Corporation (TYO:7733)
Japan · Delayed Price · Currency is JPY | Market Cap | 1.44T -37.7% |
| Revenue (ttm) | 987.51B +0.2% |
| Net Income | 84.83B +1.3% |
| EPS | 75.69 +4.6% |
| Shares Out | 1.10B |
| PE Ratio | 17.32 |
| Forward PE | 15.41 |
| Dividend | 30.00 (2.29%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 10,151,700 |
| Average Volume | 8,181,805 |
| Open | 1,315.50 |
| Previous Close | 1,340.50 |
| Day's Range | 1,302.50 - 1,338.00 |
| 52-Week Range | 1,302.50 - 2,168.00 |
| Beta | 0.17 |
| RSI | 26.97 |
| Earnings Date | May 8, 2026 |
About Olympus
Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting of CRC devices and HPB devices/hemostasis products; endoscopic solutions ecosystem products, including intelligent ecosystem operating software platfo... [Read more]
Financial Performance
In fiscal year 2025, Olympus's revenue was 997.33 billion, an increase of 6.53% compared to the previous year's 936.21 billion. Earnings were 117.86 billion, a decrease of -51.41%.
Financial StatementsNews
Q3 2026 Olympus Corp Earnings Presentation Transcript
Q3 2026 Olympus Corp Earnings Presentation Transcript
Olympus shares drop over 5% after CEO resigns over drug allegation
Shares of Japanese camera giant Olympus Corp fell on Monday after the company announced the resignation of its chief executive officer over a drug allegation. In a notice, Olympus said that it receive...
Olympus CEO steps down amid illegal drug purchase allegations; endoscope manufacturer's shares drop 7%
Olympus Corp shares fell over 7% on Monday, marking the steepest intraday decline in nearly three months, following the announcement that CEO Stefan Kaufmann had resigned from all roles effective imme...
Olympus Corp. of the Americas to Host Panel Discussion on Lung Cancer Screening Guidelines and Eligibility
Lung Cancer Awareness Month panel will examine who is at risk for lung cancer and what they need to know about the screening process and treatment options CENTER VALLEY, Pa. , Nov. 9, 2023 /PRNewswire...
Olympus Issues Request to Discontinue Use of UHI-4 Insufflator Unit, Except in Cases Where No Alternative is Available
CENTER VALLEY, Pa. , Oct. 27, 2023 /PRNewswire/ -- Olympus Corporation has announced a field corrective action in the U.S. to address complaints of adverse events from over insufflation during use of ...
Healthcare creating more opportunities for tech investors, says Harris Financial's Jamie Cox
Jamie Cox, Harris Financial Group managing partner, joins 'The Exchange' to discuss investment opportunities in medical devices, the intersection of healthcare and technology, and top picks in the med...
Olympus Corp. of the Americas Named Founders Award Winner
Company recognized for administrative professionals' career advancement initiative, OA3 CENTER VALLEY, Pa. , July 6, 2023 /PRNewswire/ -- Olympus Corp. of the Americas (OCA) announced today that it re...
Olympus Issues Voluntary Labeling Update for Bronchoscopes Used with Laser Therapy Equipment
CENTER VALLEY, Pa. , July 3, 2023 /PRNewswire/ -- Olympus Corporation has announced a voluntary field corrective action to address complaints of endobronchial combustion occurring when laser-compatibl...
Olympus nearing deal to sell microscope unit for over $2 billion - sources
Japan's Olympus Corp is close to selling its microscope unit to a private equity firm in a deal that could fetch more than 300 billion yen ($2.2 billion), three people with direct knowledge of the mat...